U.S. Supreme Court Won’t Review 3rd Circuit’s Eyedrop Class Reversal
WASHINGTON, D.C. — The U.S. Supreme Court on May 21 denied review of a prescription eyedrop case, sending the purported class action back to a New Jersey federal court for further...To view the full article, register now.
Already a subscriber? Click here to view full article